| Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis M Azami, Z Jaafari, S Rahmati, AD Farahani, G Badfar BMC ophthalmology 18, 1-14, 2018 | 86 | 2018 |
| Efficacy of intravitreal bevacizumab for zone‐II retinopathy of prematurity R Karkhaneh, A Khodabande, M Riazi‐Eafahani, R Roohipoor, ... Acta ophthalmologica 94 (6), e417-e420, 2016 | 66 | 2016 |
| Retinopathy of prematurity: incidence, risk factors, and outcome MK Sabzehei, SA Afjeh, AD Farahani, AR Shamshiri, F Esmaili Archives of Iranian medicine 16 (9), 0-0, 2013 | 47 | 2013 |
| Retinopathy of prematurity screening criteria in Iran: new screening guidelines R Roohipoor, R Karkhaneh, A Farahani, N Ebrahimiadib, B Modjtahedi, ... Archives of Disease in Childhood-Fetal and Neonatal Edition 101 (4), F288-F293, 2016 | 38 | 2016 |
| Comparison of intravitreal bevacizumab and laser photocoagulation in the treatment of retinopathy of prematurity R Roohipoor, R Karkhaneh, M Riazi-Esfahani, AD Farahani, ... Ophthalmology Retina 2 (9), 942-948, 2018 | 33 | 2018 |
| Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors F Bazvand, H Riazi-Esfahani, A Mirshahi, A Khodabande, H Khojastheh, ... International Journal of retina and vitreous 7, 1-8, 2021 | 19 | 2021 |
| Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity H Riazi-Esfahani, A Mahmoudi, M Sanatkar, AD Farahani, F Bazvand International Journal of Retina and Vitreous 7, 1-7, 2021 | 13 | 2021 |
| Internet-based versus conventional referral system for retinopathy of prematurity screening in Iran N Ebrahimiadib, R Roohipour, R Karkhaneh, A Farahani, MR Esfahani, ... Ophthalmic epidemiology 23 (5), 292-297, 2016 | 9 | 2016 |
| Automated diagnosis of plus disease in retinopathy of prematurity using quantification of vessels characteristics SM Sharafi, N Ebrahimiadib, R Roohipourmoallai, AD Farahani, ... Scientific Reports 14 (1), 6375, 2024 | 5 | 2024 |
| Intravitreal bevacizumab to treat retinopathy of prematurity in 865 eyes: a study to determine predictors of primary treatment failure and recurrence K Fadakar, M Mehrabi Bahar, H Riazi-Esfahani, A Azarkish, AD Farahani, ... International Ophthalmology 42 (7), 2017-2028, 2022 | 5 | 2022 |
| Two-year outcomes of infants with stage 2 or higher retinopathy of prematurity: results from a large multicenter registry VN Tolia, KA Ahmad, J Jacob, AS Kelleher, N McLane, RW Arnold, ... American journal of perinatology 37 (02), 196-203, 2020 | 5 | 2020 |
| Validation of the Postnatal Growth and Retinopathy of Prematurity (GROP) screening criteria K Fadakar, H Abbas, SS Shahgoli, S Tuli, A Farahani, MI Fooladi, ... Medical Hypothesis, Discovery and Innovation in Ophthalmology 11 (2), 77, 2022 | 3 | 2022 |
| Cost-effectiveness analysis of tele-retinopathy of prematurity screening in Iran SF Mohammadi, A Rahban, S Darabeigi, N Salimi, A Farahani, A Lashay, ... International Journal of Ophthalmology 14 (4), 560, 2021 | 3 | 2021 |
| Potential application of foveal structural measurements in treatment decision for retinopathy of prematurity: an OCT-based study F Bazvand, F Salari, NH Barzi, F Ghassemi, A Maleki, A Dastjani Farahani, ... International Journal of Retina and Vitreous 9 (1), 63, 2023 | 2 | 2023 |
| Ketamine Analgesia as an Alternative to General Anesthesia During Laser Treatment for Retinopathy of Prematurity M Sanatkar, A Dastjani Farahani, F Bazvand Journal of Pediatric Ophthalmology & Strabismus 59 (6), 416-421, 2022 | 2 | 2022 |
| Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti‐VEGF: A Comparison Study F Ghassemi, A Makateb, A Dastjani Farahani, A Mahmoudi, F Bazvand Journal of Ophthalmology 2022 (1), 5177401, 2022 | 2 | 2022 |
| Comparison of Ocular and Brain Abnormalities Among Neonates With In Utero Exposure to Opium or Other Drugs M Khoshnood-Shariaati, S Ashrafzadeh, A Dastjani-Farahani, R Zamani, ... Cureus 14 (8), 2022 | 1 | 2022 |
| Retinopathy Screening of Premature Neonates Born at Gestational Age 32-36 Weeks. A Naseh, A Dastjani-Farahani, B Yaghmaii, MK Shariati, ... Iranian Journal of Neonatology 13 (3), 2022 | 1 | 2022 |
| Designing a Data Mining System to Predict Treatment-Requiring Retinopathy of Prematurity in Neonates: A Pilot Study F Khorasani, AD Farahani, A Orooji, MR Zarkesh Iranian Journal of Pediatrics 31 (2), 2021 | 1 | 2021 |
| Risk factors for the time to development of retinopathy of prematurity in premature infants in Iran: a machine learning approach L Tapak, LN Farahani, NT Taleghani, N Ebrahimiadib, EK Pour, ... BMC ophthalmology 24 (1), 364, 2024 | | 2024 |
Nazanin Ebrahimiadib (Nazanin Ebra...University of Florida, Tehran University of Medical Sciences在 ufl.edu 的电子邮件经过验证
